• Published 21 Sep 2023

Dr Sam Whitmarsh to Sit on Panel Discussion at PharmaTech Integrates 2023

  • Events

CatSci Ltd is thrilled to share that our Director of Analytical Science & Digital Transformation, Dr Sam Whitmarsh, has been invited to speak at has been invited to speak on a panel discussion at PharmaTech Integrates 2023.

Sam will be giving his expert opinion on a panel discussion entitled, ‘Oligo-new-cleotides. The panel will be addressing the unique analytical, manufacture and regulatory challenges for oligonucleotides. They will also explore how the field will adapt as regulatory frameworks, market acceptance, and manufacturing techniques change.  

In partnership with CPI’s Medicines Manufacturing Innovation Centre and Life Science Integrates, this event brings together like-minded experts to discuss manufacturing technologies, strategic challenges, and the innovation required to adapt.  

Also attending the event will be Ali Albeckai, our Business Development Executive. Both Sam and Ali are excited to engage with like-minded experts in the field and discuss the future of medicines development. If you want to arrange a meeting with Sam and Ali, get in touch here.

Resources & Insights

  • 27 May 2026
Celebrating 15 Years of CatSci – From Catalysis to Integrated Drug Development Partner  
  • News
  • 11 May 2026
CatSci Achieves ISO 27001 Certification, Demonstrating its Commitment to Client Data Security
  • News
  • 1 Apr 2026
  • Jean-Baptiste Vendeville
De-Risking Suzuki Development Through Integrated HTE and DoE
  • Analytical Chemistry
  • Chemical Development
  • Design of Experiments
  • High Throughput Experimentation
  • HTE
  • Scale-up
  • Whitepapers
2 MB
  • 23 Mar 2026
HTE-Enabled Suzuki Optimisation for Cost Reduction
  • High Throughput Experimentation
  • HTE
  • Case Studies
244 KB